These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 12174889)

  • 41. Effects of two benzo[a]phenothiazines on multi-drug resistance (mdr) and tumor antigen expression.
    Molnár J; Pusztai R; Hevér A; Nagy S; Motohashi N
    Anticancer Res; 1995; 15(5B):2013-6. PubMed ID: 8572594
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of cycloartanes on reversal of multidrug resistance and apoptosis induction on mouse lymphoma cells.
    Madureira AM; Spengler G; Molnár A; Varga A; Molnár J; Abreu PM; Ferreira MJ
    Anticancer Res; 2004; 24(2B):859-64. PubMed ID: 15161038
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Interaction between various resistance modifiers and apoptosis inducer 12H-benzo[alpha]phenothiazine.
    Mucsi I; Varga A; Kawase M; Motohashi N; Molnar J
    Anticancer Res; 2002; 22(5):2833-6. PubMed ID: 12530005
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Design, synthesis, and biological properties of new bis(acridine-4-carboxamides) as anticancer agents.
    Antonini I; Polucci P; Magnano A; Gatto B; Palumbo M; Menta E; Pescalli N; Martelli S
    J Med Chem; 2003 Jul; 46(14):3109-15. PubMed ID: 12825949
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evaluation of anticancer effects of newly synthesized dihydropyridine derivatives in comparison to verapamil and doxorubicin on T47D parental and resistant cell lines in vitro.
    Bazargan L; Fouladdel S; Shafiee A; Amini M; Ghaffari SM; Azizi E
    Cell Biol Toxicol; 2008 Apr; 24(2):165-74. PubMed ID: 17805981
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Novel tetra-acridine derivatives as dual inhibitors of topoisomerase II and the human proteasome.
    Vispé S; Vandenberghe I; Robin M; Annereau JP; Créancier L; Pique V; Galy JP; Kruczynski A; Barret JM; Bailly C
    Biochem Pharmacol; 2007 Jun; 73(12):1863-72. PubMed ID: 17391647
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Anticancer and anti-inflammatory activities of 1,8-naphthyridine-3-carboxamide derivatives.
    Srivastava SK; Jaggi M; Singh AT; Madan A; Rani N; Vishnoi M; Agarwal SK; Mukherjee R; Burman AC
    Bioorg Med Chem Lett; 2007 Dec; 17(23):6660-4. PubMed ID: 17950602
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Reversal of multidrug resistance by synthetic and natural compounds in drug-resistant MCF-7 cell lines.
    Kars MD; Işeri OD; Gunduz U; Molnar J
    Chemotherapy; 2008; 54(3):194-200. PubMed ID: 18560226
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antitumor agents 260. New desmosdumotin B analogues with improved in vitro anticancer activity.
    Nakagawa-Goto K; Bastow KF; Chen TH; Morris-Natschke SL; Lee KH
    J Med Chem; 2008 Jun; 51(11):3297-303. PubMed ID: 18473435
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Multidrug resistance reversal by 3-formylchromones in human colon cancer and human mdr1 gene-transfected mouse lymphoma cells.
    Baráth Z; Radics R; Spengler G; Ocsovszki I; Kawase M; Motohashi N; Shirataki Y; Shah A; Molnár J
    In Vivo; 2006; 20(5):645-9. PubMed ID: 17091772
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antitumor activity of alkaloids derived from Amaryllidaceae species.
    Zupkó I; Réthy B; Hohmann J; Molnár J; Ocsovszki I; Falkay G
    In Vivo; 2009; 23(1):41-8. PubMed ID: 19368123
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Rational design, synthesis, and biological evaluation of bis(pyrimido[5,6,1-de]acridines) and bis(pyrazolo[3,4,5-kl]acridine-5-carboxamides) as new anticancer agents.
    Antonini I; Polucci P; Magnano A; Sparapani S; Martelli S
    J Med Chem; 2004 Oct; 47(21):5244-50. PubMed ID: 15456268
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Reversal of multidrug resistance by two nordihydroguaiaretic acid derivatives, M4N and maltose-M3N, and their use in combination with doxorubicin or paclitaxel.
    Chang CC; Liang YC; Klutz A; Hsu CI; Lin CF; Mold DE; Chou TC; Lee YC; Huang RC
    Cancer Chemother Pharmacol; 2006 Nov; 58(5):640-53. PubMed ID: 16544145
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Fluoxetine inhibits multidrug resistance extrusion pumps and enhances responses to chemotherapy in syngeneic and in human xenograft mouse tumor models.
    Peer D; Dekel Y; Melikhov D; Margalit R
    Cancer Res; 2004 Oct; 64(20):7562-9. PubMed ID: 15492283
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Rational design, synthesis, and pharmacological properties of new 1,8-naphthyridin-2(1H)-on-3-carboxamide derivatives as highly selective cannabinoid-2 receptor agonists.
    Manera C; Saccomanni G; Adinolfi B; Benetti V; Ligresti A; Cascio MG; Tuccinardi T; Lucchesi V; Martinelli A; Nieri P; Masini E; Di Marzo V; Ferrarini PL
    J Med Chem; 2009 Jun; 52(12):3644-51. PubMed ID: 19435366
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Inhibition of the MDR1 transporter by new phenothiazine derivatives.
    Kónya A; Andor A; Sátorhelyi P; Németh K; Kurucz I
    Biochem Biophys Res Commun; 2006 Jul; 346(1):45-50. PubMed ID: 16750172
    [TBL] [Abstract][Full Text] [Related]  

  • 57. 1,8-Naphthyridine-3-carboxamide derivatives with anticancer and anti-inflammatory activity.
    Kumar V; Jaggi M; Singh AT; Madaan A; Sanna V; Singh P; Sharma PK; Irchhaiya R; Burman AC
    Eur J Med Chem; 2009 Aug; 44(8):3356-62. PubMed ID: 19361894
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Synthesis and biological evaluation of indazolo[4,3-bc][1,5]naphthyridines (10-aza-pyrazolo[3,4,5-kl]acridines): a new class of antitumor agents.
    Magnano A; Sparapani S; Lucciarini R; Michela M; Amantini C; Santoni G; Antonini I
    Bioorg Med Chem; 2004 Nov; 12(22):5941-7. PubMed ID: 15498670
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Structure-activity relationships of some taxoids as multidrug resistance modulator.
    Hasegawa T; Bai J; Zhang S; Wang J; Matsubara J; Kawakami J; Tomida A; Tsuruo T; Hirose K; Sakai J; Kikuchi M; Abe M; Ando M
    Bioorg Med Chem Lett; 2007 Feb; 17(4):1122-6. PubMed ID: 17239597
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Inhibition of P-glycoprotein transport activity in a resistant mouse lymphoma cell line by diterpenic lactones.
    Ferreira MJ; Gyémánt N; Madureira AM; Molnár J
    Anticancer Res; 2005; 25(5):3259-62. PubMed ID: 16101136
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.